Edition:
United States

Catabasis Pharmaceuticals Inc (CATB.OQ)

CATB.OQ on NASDAQ Stock Exchange Global Market

1.61USD
25 Apr 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$1.61
Open
--
Day's High
--
Day's Low
--
Volume
100
Avg. Vol
119,973
52-wk High
$3.78
52-wk Low
$1.09

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Dec '17 0.25 -0.237
Sep '17 0.25 -0.311
Jun '17 0.00 -0.320
Mar '17 0.00 -0.412
FY 2016 Dec '16 0.00 -0.469
Sep '16 0.00 -0.543
Jun '16 0.00 -0.614
Mar '16 0.00 -0.614
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 2 0.00 0.00 0.00 0.00
Quarter Ending Sep-18 2 0.00 0.00 0.00 0.00
Year Ending Dec-18 2 0.12 0.25 0.00 0.00
Year Ending Dec-19 2 0.00 0.00 0.00 0.72
Earnings (per share)
Quarter Ending Jun-18 3 -0.21 -0.17 -0.24 -0.55
Quarter Ending Sep-18 3 -0.22 -0.20 -0.23 -0.57
Year Ending Dec-18 3 -0.85 -0.77 -0.92 -1.77
Year Ending Dec-19 3 -1.19 -0.71 -1.64 -1.99
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 173.69 32.21
P/E High - Last 5 Yrs. -- 277.43 45.93
P/E Low - Last 5 Yrs. -- 94.83 24.67
Beta -- 0.74 0.79
Price to Sales (TTM) 95.23 143.31 7.12
Price to Book (MRQ) 3.23 18.56 4.90
Price to Tangible Book (MRQ) 4.04 23.03 6.48
Price to Cash Flow (TTM) -- 113.95 24.70
% Owned Institutions 35.09 11.14 2.29

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.57
Dividend Yield - 5 Year Avg -- 0.20 0.77
Dividend 5 Year Growth Rate -- 1.99 4.07
Payout Ratio(TTM) -- 9.34 20.78

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 102.04 9.38
Sales (TTM) vs TTM 1 Yr. Ago -- 78.42 11.18
Sales - 5 Yr. Growth Rate -- 33.22 8.21
EPS (MRQ) vs Qtr. 1 Yr. Ago 49.61 -68.08 24.18
EPS (TTM) vs TTM 1 Yr. Ago 42.87 -- --
EPS - 5 Yr. Growth Rate -- 45.94 10.39
Capital Spending - 5 Yr. Growth Rate -30.83 44.70 10.42

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.72 2.53
Current Ratio (MRQ) 2.90 5.98 3.59
LT Debt to Equity (MRQ) 0.00 23.74 11.47
Total Debt to Equity (MRQ) 21.02 26.24 14.16
Interest Coverage (TTM) -59.76 -176.11 30.45

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 34.08 54.23
Gross Margin - 5 Yr. Avg. -- 55.28 52.19
EBITD Margin (TTM) -5,358.00 -- --
EBITD - 5 Yr. Avg -26,528.40 -148.90 15.91
Operating Margin (TTM) -5,418.80 -586.11 3.78
Operating Margin - 5 Yr. Avg. -26,822.20 -161.04 11.22
Pre-Tax Margin (TTM) -5,472.80 -558.30 4.45
Pre-Tax Margin - 5 Yr. Avg. -27,211.20 -168.34 11.53
Net Profit Margin (TTM) -5,472.80 -546.50 1.07
Net Profit Margin - 5 Yr. Avg. -27,211.20 -168.59 7.86
Effective Tax Rate (TTM) -- -0.47 31.76
Effective Tax Rate - 5 Yr. Avg. -- 18.03 24.25

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 23,213,484 790,924,504
Net Income/Employee (TTM) -- 651,754 92,823,068
Receivable Turnover (TTM) -- 6.13 5.51
Inventory Turnover (TTM) -- 2.42 3.47
Asset Turnover (TTM) 0.02 0.40 0.88

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -94.19 -0.73 10.41
Return on Assets - 5 Yr. Avg. -83.24 0.50 11.41
Return on Investment (TTM) -125.05 -0.70 13.05
Return on Investment - 5 Yr. Avg. -99.87 4.02 14.78
Return on Equity (TTM) -133.88 -2.69 14.90
Return on Equity - 5 Yr. Avg. -- -0.12 16.12
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 43.19 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Catabasis Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 35.09%
# of Holders: 32
Total Shares Held: 10,189,833
3 Mo. Net Change: 938,842
# New Positions: 3
# Closed Positions: 2
# Increased Positions: 3
# Reduced Positions: 3
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.